On linezolid efficacy and tolerability
- PMID: 22379150
- DOI: 10.1183/09031936.00116011
On linezolid efficacy and tolerability
Similar articles
-
Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.Pediatr Infect Dis J. 2011 Sep;30(9):812-3. doi: 10.1097/INF.0b013e3182154b05. Pediatr Infect Dis J. 2011. PMID: 21378593
-
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.Int J Tuberc Lung Dis. 2012 Dec;16(12):1588-93. doi: 10.5588/ijtld.12.0322. Epub 2012 Oct 2. Int J Tuberc Lung Dis. 2012. PMID: 23032215
-
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8. J Antimicrob Chemother. 2009. PMID: 19666903 No abstract available.
-
[The analysis of clinical data about the treatment of linezolid against tuberculosis].Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):601-3. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24252739 Review. Chinese. No abstract available.
-
Linezolid.Tuberculosis (Edinb). 2008 Mar;88(2):122-5. doi: 10.1016/S1472-9792(08)70014-3. Tuberculosis (Edinb). 2008. PMID: 18486048 Review. No abstract available.
Cited by
-
New anti-tuberculosis drugs and regimens: 2015 update.ERJ Open Res. 2015 May 6;1(1):00010-2015. doi: 10.1183/23120541.00010-2015. eCollection 2015 May. ERJ Open Res. 2015. PMID: 27730131 Free PMC article. Review.
-
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres.BMC Infect Dis. 2019 Jun 28;19(1):564. doi: 10.1186/s12879-019-4211-0. BMC Infect Dis. 2019. PMID: 31253115 Free PMC article.
-
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.Int J Mol Sci. 2017 Feb 7;18(2):341. doi: 10.3390/ijms18020341. Int J Mol Sci. 2017. PMID: 28178199 Free PMC article.
-
Tuberculosis elimination: where are we now?Eur Respir Rev. 2018 Jun 13;27(148):180035. doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30. Eur Respir Rev. 2018. PMID: 29898905 Free PMC article. Review.
-
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.Ann Clin Microbiol Antimicrob. 2016 Jun 22;15(1):41. doi: 10.1186/s12941-016-0156-y. Ann Clin Microbiol Antimicrob. 2016. PMID: 27334498 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources